Needs - Your Resource for Health and Wellness
Call Toll Free: 1.800.634.1380
Listen and Learn
Teleseminar Speaker "How to Corona-Proof Your Life Follow Up" with Dr. Sherry Rogers.
spacer spacer
About TransFirst®
Card Acceptance
Doctor's Best Authorized Online Retailer

The New Gold Standard for Menopausal Relief
Submitted by Metagenics

Estrovera is a natural option that features ERr 731, a special extract of Siberian rhubarb, demonstrated in clinical studies to significantly reduce menopausal symptoms—offering an effective and safer option for both peri- and postmenopausal women.*

Effective Relief for Menopausal Symptoms*
Clinically shown to dramatically reduce the number of daily hot flashes and relieve a wide range of other symptoms.*

Efficacy Comparable to Hormone Therapies*
Demonstrated to relieve hot flashes to a similar extent as estrogen-based therapies and exceed reported results of other phytoestrogen and botanical approaches.*

Unprecedented Scientific Validation for a Phytoestrogen Approach*
Multiple short- and long-term studies with over 400 peri- and postmenopausal women— published in peer-reviewed journals—confirm efficacy and predicted safety*. For example:

  • In a 12-week clinical study with ERr 731, perimenopausal women reported significant improvements in symptoms—including hot flashes and anxiety—within just 28 days (compared to placebo)*3,4

  • In another 12-week clinical study, ERr 731 reduced average number of daily hot flashes from 12 to 2*5

  • In a six-month study, ERr 731 demonstrated progressive relief of multiple symptoms measured by the Menopause Rating Scale (MRS), including:*1

    • Negative mood, irritability & anxiety

    • Joint and muscle discomfort

    • Physical/mental exhaustion

    • Sleep disturbances

    • Hot flashes/night sweats
  • In a two-year study with ERr 731, ~83% reduction of the total MRS II score was maintained from 60 weeks to 108 weeks*2

  • Estrovera provides a clinically effective dose of ERr 731 in just 1 tablet daily*

  • Excellent Safety Profile*
    ERr 731 has been professionally recommended for over 20 years with no serious adverse events reported and no clinically relevant changes in safety parameters have been observed in clinical trials.*

    1. Altern Ther Health Med. 2008;14(6):32-38.
    2. Menopause. 2009;16(1):117-131.
    3. Menopause. 2006;13(5):744-759.
    4. Menopause. 2007;14(2):270-283.
    5. Altern Ther Health Med. 2009;15(1):24-34.

    *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

    Related Products
    Protective Breast Formula